| 发明名称 |
Edg receptor agonists |
| 摘要 |
The present invention encompasses compounds of Formula 1: as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
|
| 申请公布号 |
US2005033055(A1) |
申请公布日期 |
2005.02.10 |
| 申请号 |
US20040500895 |
申请日期 |
2004.07.07 |
| 申请人 |
BUGIANESI ROBERT L.;DOHERTY GEORGE A.;GENTRY AMY;HALE JEFFREY J.;LYNCH CHRISTOPHER L.;MILLS SANDER G.;NEWAY III WILLIAM E. |
发明人 |
BUGIANESI ROBERT L.;DOHERTY GEORGE A.;GENTRY AMY;HALE JEFFREY J.;LYNCH CHRISTOPHER L.;MILLS SANDER G.;NEWAY III WILLIAM E. |
| 分类号 |
A61K31/397;A61K31/40;A61K31/4025;A61K31/41;A61K31/4155;A61K31/4245;A61K31/675;A61P1/02;A61P1/04;A61P1/16;A61P3/10;A61P5/14;A61P7/06;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P17/00;A61P17/04;A61P17/06;A61P17/14;A61P19/02;A61P19/10;A61P21/00;A61P21/04;A61P25/00;A61P25/06;A61P27/02;A61P27/12;A61P29/00;A61P31/14;A61P31/20;A61P35/00;A61P35/04;A61P37/02;A61P37/06;A61P37/08;C07D205/04;C07D207/16;C07D403/04;C07D403/12;C07D405/12;C07D409/12;C07D413/10;C07D413/14;C07F9/572;C07F9/6558;(IPC1-7):C07F9/547;C07D207/08;C07D211/34 |
主分类号 |
A61K31/397 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
